These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 3915958)

  • 21. Effects of fluoride on bone in chronic renal failure.
    Lough J; Noonan R; Gagnon R; Kaye M
    Arch Pathol; 1975 Sep; 99(9):484-7. PubMed ID: 1164250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia.
    Boyce BF; Byars J; McWilliams S; Mocan MZ; Elder HY; Boyle IT; Junor BJ
    J Clin Pathol; 1992 Jun; 45(6):502-8. PubMed ID: 1624597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.
    O'Brien AA; Moore DP; Keogh JA
    Ir J Med Sci; 1990 Mar; 159(3):74-6. PubMed ID: 2361823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of aluminum in the development of osteomalacia in patients on chronic hemodialysis].
    Adamiec R; Uzar J
    Pol Arch Med Wewn; 1988 Jan; 79(1):3-12. PubMed ID: 3275167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization.
    Costantini S; Bonucci E; Mocetti P; Ballanti P; Giordano R; Vernillo I; Ioppolo A; Mantovani A; Stasolla D
    Ann Ist Super Sanita; 1986; 22(2):689-95. PubMed ID: 3752831
    [No Abstract]   [Full Text] [Related]  

  • 29. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
    Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
    Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in bone histology after treatment with desferrioxamine.
    Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract]   [Full Text] [Related]  

  • 31. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats.
    Oste L; Bervoets AR; Behets GJ; Dams G; Marijnissen RL; Geryl H; Lamberts LV; Verberckmoes SC; Van Hoof VO; De Broe ME; D'Haese PC
    Kidney Int; 2005 Mar; 67(3):920-30. PubMed ID: 15698431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteomalacia and bone disease arising from aluminum.
    Coburn JW; Norris KC; Nebeker HG
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract]   [Full Text] [Related]  

  • 34. Iron overload and bone disease in chronic dialysis patients.
    Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1990; 5(9):781-7. PubMed ID: 2129351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
    Wills MR; Savory J
    Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
    Sedman AB; Alfrey AC; Miller NL; Goodman WG
    J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
    Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
    Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The general principles of the diagnosis of dialysis osteomalacia by the results of the histomorphometry of spongy bone].
    Novikov AI; Ivanov AE; Golovniak IE; Baeva LB; Levitskiĭ ER
    Ter Arkh; 1991; 63(12):107-10. PubMed ID: 1803585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strontium causes osteomalacia in chronic renal failure rats.
    Schrooten I; Cabrera W; Goodman WG; Dauwe S; Lamberts LV; Marynissen R; Dorriné W; De Broe ME; D'Haese PC
    Kidney Int; 1998 Aug; 54(2):448-56. PubMed ID: 9690211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Animal model of aluminum-induced osteomalacia: role of chronic renal failure.
    Robertson JA; Felsenfeld AJ; Haygood CC; Wilson P; Clarke C; Llach F
    Kidney Int; 1983 Feb; 23(2):327-35. PubMed ID: 6842959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.